Skip to content

MDMA: all studies

Page 108 of 347: studies 1,071 to 1,080 of 3,461, newest first. Back to the MDMA overview

Research

Profile of MDMA Self-Administration from a Large Cohort of Rats: MDMA Develops a Profile of Dependence with Extended Testing

Journal of Drug and Alcohol Research 2012 Susan Schenk, Joyce Colussi‐mas, Jennifer Do et al. 38 citations

The present study provides a profile of acqui- sition and maintenance of self-administration of +/-3,4- methylenedioxymethamphetamine (MDMA) obtained from a large cohort of rats tested during a 2 year period. Of the 128 rats, 49% self-administered 1.0 mg/kg/infusion MDMA to an initial criterion within a 25 day cut-off period. The number of test sessions required to meet this initial criterion...

DOI: 10.4303/jdar/235602 (opens in new tab) MDMA Cohort Administration probate law Pharmacology

MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?

Frontiers in Genetics 2012 Rafael de la Torre, Samanta Yubero‐lahoz, Ricardo Pardo‐lozano et al. 108 citations

In vitro human studies show that the metabolism of most amphetamine-like psychostimulants is regulated by the polymorphic cytochrome P450 isozyme CYP2D6. Two compounds, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA), were selected as archetypes to discuss the translation and clinical significance of in vitro to in vivo findings. Both compounds were chosen based on their...

DOI: 10.3389/fgene.2012.00235 (opens in new tab) MDMA Pharmacogenetics Cyp2d6 Methamphetamine +1

Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Neuropharmacology December 2011 Erica Y Shen, Syed F. Ali, Jerrold S. Meyer

Most recreational users of 3, 4-methylenedioxymethamphetamine (MDMA or "ecstasy") also take cannabis, in part because cannabis can reduce the dysphoric symptoms of the ecstasy come-down such as agitation and insomnia. Although previous animal studies have examined the acute effects of co-administering MDMA and Δ(9)-tetrahydrocannabinol (THC), which is the major psychoactive ingredient in...

Reward sensitivity and outcome expectancies as predictors of ecstasy use in young adults.

Addictive Behaviors December 2011 Melanie J Smerdon, Andrew J P Francis

Extending recent studies showing that sensitivity to reward and outcome expectancies are associated with problematic alcohol and cannabis use, we undertook to determine if similar relationships would hold for ecstasy. One hundred and twenty five males and females aged between 18 and 35years were recruited from RMIT University and through snowball sampling. Participants completed a questionnaire...

Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA

Journal of Neuroinflammation December 1, 2011 Andrea Mayado, Elisa Torres, Maria D Gutierrez-Lopez et al. 8 citations

AbstractBackgroundPreconditioning is a phenomenon by which tolerance develops to injury by previous exposure to a stressor of mild severity. Previous studies have shown that single or repeated low dose MDMA can attenuate 5-HT transporter loss produced by a subsequent neurotoxic dose of the drug. We have explored the mechanism of delayed preconditioning by low dose MDMA.MethodsMale Dark Agouti...

Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)

Journal of Neuroscience November 23, 2011 Benjamin Di Cara, Roberto Maggio, Gabriella Aloisi et al. 97 citations

“Ecstasy” [3,4-methylenedioxymetamphetamine (MDMA)] is of considerable interest in light of its prosocial properties and risks associated with widespread recreational use. Recently, it was found to bind trace amine-1 receptors (TA 1 Rs), which modulate dopaminergic transmission. Accordingly, using mice genetically deprived of TA 1 R ( TA 1 -KO ), we explored their significance to the actions of...

Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants.

Toxicology November 18, 2011 Irene Antolino-Lobo, Jan Meulenbelt, Jeffrey Molendijk et al.

MDMA (3,4-methylenedioxymethamphetamine) metabolism is a major cause of MDMA-mediated hepatotoxicity. In this study the effects of MDMA and its metabolites on the glutathione system were evaluated. Glutathione (GSH/GSSG) levels and gene expression of glutamate cysteine ligase catalytic subunit (GCLC), glutathione-S-transferase (GST) and pregnane X receptor (PXR) were compared in the...

Association of study characteristics with estimates of effect size in studies of ecstasy use.

Journal of Psychopharmacology November 2011 Eleanor M Taylor, Natasha M P Greene, Celia J. A. Morgan et al.

Studies of the chronic effects of MDMA, or 'ecstasy', in humans have been largely inconsistent. We explored whether study-level characteristics are associated with the effect size estimate reported. We based our analyses on the recent systematic review by Rogers and colleagues, focusing on those meta-analyses within this report where there was a relatively large number of studies contributing...

Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice.

Psychopharmacology November 2011 Marta Rodríguez‐arias, Concepción Maldonado, Antonio Vidal-Infer et al.

Heavy binge drinking is increasingly frequent among adolescents, while ethanol (EtOH) is often used in combination with 3,4-methylenedioxymethamphetamine (MDMA). The long-lasting effects of intermittent exposure to EtOH and MDMA during adolescence on motor activity, anxiety, and social behavior were evaluated in adult mice. The concentration of brain monoamines in the striatum, cortex, and...

Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference.

Pharmacology, Biochemistry, and Behavior November 2011 Manuel Daza‐losada, José Miñarro, María A. Aguilar et al.

Cannabis is one of the drugs most commonly consumed in combination with ecstasy (3,4-methylenedioxymethamphetamine, MDMA). Although numerous studies have attempted to further our understanding of the role of the cannabinoid system in drug abuse, few have focused on how it influences the rewarding effects of MDMA. The aim of the present study was to evaluate the role of the CB1 cannabinoid...